While viral vectors are efficient at delivering genes into cells, there are also non-viral methods that can be used for liver transfection. Non-viral methods generally have lower transfection efficiency, but they have the advantage of being less likely to induce immune responses and having larger cargo capacities. Here are some non-viral methods used for liver…

Viral vectors are common tools used in gene therapy due to their natural ability to infect cells and integrate their genetic material. Each type of viral vector has its unique features, advantages, and limitations. Here are the main types of viral vectors used for liver transfection: In choosing a viral vector for liver transfection, researchers…

Gene therapy has the potential to provide a one-time, curative treatment for a variety of liver diseases, including those caused by single gene defects such as Hemophilia A and B, Wilson disease, and alpha-1-antitrypsin deficiency, among others. The liver is an ideal organ for gene therapy because it has a high regenerative capacity and can…

Transfection is the process of deliberately introducing nucleic acids into cells. In the context of the liver, this technique can be used to study gene function, protein expression, or to potentially correct genetic defects. Here are some commonly used methods for liver transfection: It’s important to note that each of these methods has its own…

The H22 cell line is a mouse hepatocellular carcinoma (HCC) cell line commonly used in cancer research. The H22 cell line was originally derived from a chemically induced hepatoma in a Balb/c mouse. The H22 cell line is characterized by its rapid growth rate and aggressive behavior, making it a useful model for studying HCC…

The Hepa 1-6 cell line is a mouse hepatoma cell line that was originally derived from a hepatocellular carcinoma induced in a C57BL/6 mouse. The Hepa 1-6 cell line is widely used as a model system in cancer research to study hepatocellular carcinoma biology and to evaluate potential therapies for this disease. The Hepa 1-6…

The Hep3B cell line is a human hepatocellular carcinoma cell line that was derived from a male patient with hepatocellular carcinoma. The Hep3B cell line is commonly used in cancer research to study hepatocellular carcinoma biology and to evaluate potential therapies for this disease. The Hep3B cell line is characterized by its high tumorigenicity, rapid…

The HepG2 cell line is a human hepatocellular carcinoma cell line that was originally derived from a liver biopsy from a 15-year-old male patient with hepatocellular carcinoma. The HepG2 cell line is commonly used in cancer research to study hepatocellular carcinoma biology and to evaluate potential therapies for this disease. The HepG2 cell line is…

The SK-Hep-1 cell line is a human hepatocellular carcinoma cell line that was originally derived from a liver biopsy of a 52-year-old female patient with hepatocellular carcinoma. The SK-Hep-1 cell line is commonly used in cancer research to study hepatocellular carcinoma biology and to evaluate potential therapies for this disease. The SK-Hep-1 cell line is…

The SMMC-7721 cell line is a human hepatocellular carcinoma cell line that was originally derived from a liver biopsy of a 56-year-old male patient with hepatocellular carcinoma. The SMMC-7721 cell line is commonly used in cancer research to study hepatocellular carcinoma biology and to evaluate potential therapies for this disease. The SMMC-7721 cell line is…